medigraphic.com
ISSN 0188-9796 (Impreso)

2005, Número 1

<< Anterior Siguiente >>

Rev Endocrinol Nutr 2005; 13 (1)


Sangrado uterino anormal (y el endocrinólogo)

Alanís FJ, Zacarías CR, Aragón HJP

Idioma: Español
Referencias bibliográficas: 52
Paginas: 39-45
Archivo PDF: 91.57 Kb.


RESUMEN

El sangrado uterino anormal se puede presentar en un alto porcentaje de la población femenina y depende no sólo del manejo ginecológico, ya que al estar involucradas diversas patologías se requiere que su estudio y tratamiento sea multidisciplinario. En su abordaje deben tenerse en cuenta varios factores como son: la edad de la paciente, paridad y problemas de infertilidad. Se mencionan las vías y rutas para su estudio y los tratamientos hormonales y quirúrgicos que se lleguen a requerir.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Vasilenko P, Kraicer PF, Kaplan R, de Masi A, Free N. A new and simple method of measuring blood loss. J Reprod Med 1988; 33: 293-297.

  2. Van Eijkeren MA, Christiaens GCML, Sixma JJ, Haspels AA. Menorrhagia a review. Obstet Gynecol Surv 1989; 44: 421-429.

  3. Stewart EA, Nowak RA. Leiomyoma related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod 1996; 2: 295-306.

  4. Englud K, Blanck A, Gustavsson I, Lundkvist U, Sjoblom P, Norgen et al. Sex steroid receptors in human myometrium and fibroids: changes during menstrual cycle and gonadotropin-releasing treatment. J Clin Endocrinol Metab 1998; 83: 4092-4096.

  5. Yoshida M, Ohtsuru A, Somejima T, Okassaki M, Fujishita A, Ito M et al. Involvement of parathyroid hormone-related peptide in proliferation activity of human uterine leiomyomas. Endocr J 1999; 46: 81-90.

  6. Marsh MM, Malakooti N, Taylor NH, Findlay JK, Salamonsen LA. Endothelin and neutral endopeptidase in the endometrium of women with menorrhagia. Human Reprod 1997; 12: 2036-2040.

  7. Dawodd V, Med M, Sabin N. Growth factors and leiomiomas. Infertility and Reproductive Medicine Clinics of North America 1996: 5-18.

  8. Rogers PA, Lederman F, Kooy J, Taylor NH, Healy DL. Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Human Reprod 1996; 11: 2003-2008.

  9. Brenner PF. Introduction to management of bleeding disorders in women: the role of the obstetricians-Gynecologist. Am J Obstet Gynecol 1996; 175: 761-762.

  10. Makarainen L, Ylikorkala O. Primary and myoma associated menorrhagia; role of prostaglandins and effects of ibuprofen. Br J Obstet Gynecol 1986; 93: 974-978.

  11. Cocharane R, Regan L. Undetected gyneacological disorders in woman with renal disease. Human Reprod 1997; 12: 67-70.

  12. Brenner PF. Differential diagnosis of abnormal uterine bleeding. Am J Obstet Gyneacol 1996; 175: 766-769.

  13. Maia Jr HH, Maltez A, Oliveira M et al. Diagnosis and treatment of abnormal uterine bleeding in postmenopausal patient using hormone replacement therapy. Gynaecol Endoscopy 1998; 7: 319-325.

  14. Ruggeeri ZM. Pathogenesis and classification of Von Willebrand disease. Hemostasis 1994; 24: 265-275.

  15. Luscher JM. Screening and diagnosis of coagulation disorders. Am J Obstet Gynecol 1996; 175: 778-783.

  16. Weiss Case representations: a patient with Von Willebrand disease with metrorrhagia. Am J Obstet Gynecol 1996; 175: 763-765.

  17. Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Am J Obstet Gynecol 1996; 174: 1678-1682.

  18. Wood C, Maher P, Hill D. Biopsy diagnosis and conservative surgical treatment of adenomyosis. J Am Assoc Gynecol Laparosc 1994; 1: 313-316.

  19. Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS. Magnetic resonance imaging for diagnostic adenomyomata. J Am Assoc Gynecol Laparosc 1996; 3: 245-250.

  20. Ben Hmid R, Mahjoub S, Boughizane et al. Value of ambulatory diagnostic hysteroscopy. A review of a series of 292 cases. Tunis Med 2000; 78(10): 600-606.

  21. Leyva J, Morales-Arce J, Bustos-López HH. Histerosonografía. Utilidad en Ginecología. Rev Perinatol 1998; (en prensa).

  22. Turner RT, Berman AM, Topel HC. Improved demonstration of endometrial polyps and submucous myomas using saline-enhanced vaginal sonohysterography. J Am Assoc Gynecol Laparosc 1995; 2: 421-425.

  23. Derman SG, Rehnstrom J, Neuwirth RS. The long term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991; 77: 591-594.

  24. Wortman M, Daggett A. Hysteroscopic management of intractable uterine bleeding. A review of 103 cases. J Reprod Med 1993; 38: 505-510.

  25. Serden SP, Brooks PG. Treatment of abnormal uterine bleeding with the gynecologic resectoscope. J Reprod Med 1991; 36: 697-699.

  26. Valle RF. Medical treatment of abnormal bleeding and preparation of the uterus for hysteroscopic surgery. Am Assoc Gynecol Laparosc 50-55.

  27. Goldrath MH. Use of Danazol in hysteroscopic surgery for menorrhagia. J Reprod Med 1990; 35: 91-96.

  28. Anderson MM, Irwin CE Jr, Snyder DL. Abnormal vaginal bleeding in adolescents. Pediatr Ann 1986; 15: 697-707.

  29. Chuong CJ, Brenner PF. Management of Uterine Bleeding. Am J Obstet Gynecol 1996; 175: 787-792.

  30. Sorensen SS, Colov NP, Vejerlev LO. Pre and postoperative, randomized study. Acta Obstet Scand 1997; 76: 340-344.

  31. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: Randomized controlled trial of ethamsylate, mefenamic acid and trenaxamic acid. Br Med J 1996; 313: 579-582.

  32. Carlson KJ, Schiff I. Alternatives to hysterectomy for menorrhagia. N Engl J Med 1996; 335: 198-199.

  33. O’Connor H, Magos A. Endometrial resection for the treatment of menorrhagia. N Engl J Med 1996; 335: 151-156.

  34. O’connor H, Broadbent JAM, Magos AL, McPherson K. Medical council randomized trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet 1997; 340: 897-901.

  35. Glasser MH. Endometrial ablation and hysteroscopic myomectomy electrosurgical vaporization. J Am Assoc Laparosc 1997; 4: 369-374.

  36. Ewenstein BM. The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding. Am J Obstet Gynecol 1996; 175: 770-777.

  37. Farquar CM, Kimble RM. How do New Zealand gynecologist treatment of menorrhagia. Auzt NZ J Obstet Gyneacol 1996; 36: 444-447.

  38. Munro MG. Medical management of abnormal uterine bleeding. Obstet Gynecol Clin North Am 2000; 27(2): 287-304.

  39. Thomas EJ. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids. Br Obstet Gyneacol 1996; 103: 18-21.

  40. Hansen LM, Batzer FR, Corson SL, Bello S. Obesity and GnRH action. Report a case with contribution by peripherally derived estrogens. J Reprod Med 1997; 42: 247-250.

  41. Sato F, Nishi M, Kudo R, Miyake H. Body fat distribution and uterine leiomyomas. J Epidemiol 1998; 8: 176-180.

  42. Bettocchi S, Lovero G, Pansini N, Selvaggi L. Outpatient hysteroscopy. J Am Assoc Gynecol Laparosc 1995; 2(4 Suppl): S3-S4.

  43. Barrington JW, Bowen-Simpkins P. Levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet 1997; 104: 614-616.

  44. Wortman M, Dagget A. Hysteroscopic myomectomy. J Assoc Gynecol Laparosc 1995; 3: 39-46.

  45. Brooks PG, Serden SP. Hysteroscopic findings after unsuccessful dilatation and curettage for abnormal uterine bleeding. Am J Obstet Gynecol 1988; 158: 1354-1357.

  46. Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling: sensitivity in the detection of endometrial cancer. J Reprod Med 1995; 40: 553-555.

  47. Baggish MS, Sze EH. Endometrial ablation: a series of 568 patients treated over an 11 year period. Am J Obstet Gynecol 1996; 174: 908-913.

  48. Rein M, Friedman A, Stuart J et al. Fibroid and myometrial steroid receptors in woman treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 1990; 53: 1018-1023.

  49. Matsuma Y, Yamashita Y, Takahashi M et al. Predicting the effect of gonadotropin releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging. Acta Radiol 1999; 40: 656-662.

  50. Palomba S, Afinito P, Tommaselli GA, Nappi C. A clinical trial of the effects of tibolone administered with gonadotropic. Releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 1998; 70: 111-118.

  51. González M. Ginecología. Salvat editores. 5 ed. cap 10 Hemorragias Uterinas anormales, pp. 174-180.

  52. Wamsteker K, De Block S. Diagnostic Hysteroscopy: Technique and documentation. In: Sutton CIG, Diamond M, (eds). Endoscopic Surgery for Gyneacologist. Londres. Londres: WB Saunders, 1993: 263-276.




2020     |     www.medigraphic.com